Skip to content

Clinical trials

Phase 3 Ocular Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 3 Country / region: United States Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20017
20035
20054
20061
20071
20104
20121
20134
20146
20155
20162
20187
20194
20203
20213
20222
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61
Recruiting6
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research13
Allergan13
Aerie Pharmaceuticals6
AbbVie4
Bausch & Lomb Incorporated4
Glaukos Corporation3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Santen Inc.3
Sun Pharma Advanced Research Company Limited3
Nicox Ophthalmics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension70
Glaucoma, Open-Angle46
Glaucoma33
Hypertension4
Cataract2
Glaucoma, Angle-Closure1

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.